Flarin Holdings Limited (FHL), trading through its subsidiary Infirst Limited, today announces that it has appointed Capel Thompson & Homer LLP (CTH) as advisor to assist in seeking a licensing partner for its patented lipid NSAID technology in the USA and other geographies.